Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking therapy may ease period pain in teens

NCT ID NCT07555886

Symptom relief Sponsor: Universidad Autonoma de Baja California Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a psychological program for teens aged 15-19 with painful periods. The program uses cognitive restructuring and psychoeducation to help them change negative thoughts and improve emotional control. Researchers will measure pain and coping skills before and after the program in 35 participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cognitive restructuring techniques and psychoeducation
What this could lead to
If it works, this could offer a drug-free way to reduce menstrual pain and improve emotional coping in teens.
What could go wrong
This is a very small, early study with only 35 participants and no control group, so results may not be reliable or generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 35 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 18 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria Gender: menstruating individuals in late adolescence. * Age: 15 to 19 years. * Estimated IQ above 80. * With painful menstrual cycles (primary dysmenorrhea) without a prior gynecological diagnosis. * Students at the institution selected for the intervention. * Written expression of willingness and interest in participating in the program (informed consent in the case of minors) * Informed consent signed by parents (in the case of minors) or by the participants (in the case of adults). * Attendance of at least 70% of the intervention sessions. Exclusion criteria * Ages other than those previously indicated. * An estimated IQ below 80. * A prior gynecological diagnosis of a condition other than dysmenorrhea. * Pharmacological or hormonal treatment that could, in and of itself, interfere with executive functions, pain perception, and emotional regulation. * With psychiatric and/or neurological conditions that, in and of themselves, affect executive functions and emotional regulation. * With pain-free menstrual cycles. * Lack of interest or willingness to participate in the program * Lack of informed consent or assent. Elimination criteria * Voluntary withdrawal from the program. * Missing more than 30% of the sessions. * Withdrawal of informed consent (personal, from guardians, or institutional). * Receiving a diagnosis that meets any of the exclusion criteria during the -intervention program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menstrual cramps are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dysmenorrhea Emotional Regulation primary dysmenorrhea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Menstrual cramps

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universidad Autonoma de Baja California

    Mexicali, Estado de Baja California, 21700, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.